Bio-IT World October 17, 2024
Bio-IT World Staff

Illumina unveiled its MiSeq i100 Series of sequencing systems last week during an online customer event, comprising two new benchtop instruments: MiSeq i100 and MiSeq i100 Plus Systems. The MiSeq i100 will be available to ship globally in 2025.

The company says the new sequencing systems offer an affordable, comprehensive solution that is simple to understand and use, even for those with limited NGS expertise.

“Our customers told us they need a faster, smaller, and easy-to-use instrument, and that’s what we’re delivering with the MiSeq i100,” said Jacob Thaysen, PhD, CEO of Illumina, in a press release. He called the i100 series, “the plug-and-play flexibility that today’s labs are seeking.”

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma / Biotech, Precision Medicine
Bringing genomics closer to patients: 3 takeaways from Henry Ford Health
Oncologist talks personalized medicine for pancreatic cancer
AI offers a step above genomic solutions
How Mayo Clinic is using real-world data to advance precision medicine
Aignostics Secures $34 Million Series B to Enhance Precision Medicine with AI

Share This Article